Skip to content
buyWeak cluster of 2

Christer Rosen bought $7,986 of JUNS

CEO and Chairman at JUPITER NEUROSCIENCES, INC.. 7,816 shares at an average of $1.02, traded Jun 27, 2025, filed Jul 1, 2025.

Conviction score
28
Value
$7,986
7,816 shares
Holdings after
11,075,292
+0% from before
From 52-week low
-
no price yet
From 52-week high
-
no price yet

Score components

  • Role
    CEO
    +25
  • Trade size
    $8k at market
    0
  • Relative to holdings
    Under 1% of holdings (0.1%)
    -5
  • Price context
    No price history yet
    0
  • Cluster
    2 insiders buying within 14 days
    +8
  • Repeat buying
    First buy in 90 days
    0
  • Track record
    Too few past buys to judge (0 with prices)
    0

What happened after comparable buys

Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.

This signal so far: 1m +38.6%, 3m +74.3%, 6m +6.8%.

Price around the trade, and since

From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.

JUNSOct 9, 2026 · close 2.85
Since filing Jul 1, 2025: -96.2%SPY +27.8% · excess -124.0%

Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™

Rows in this filing

Every transaction in Form 4 0001641172-25-017416, as filed. Open on EDGAR

DateTransactionSharesPriceValueHoldings afterFiled
Jun 2, 2025MOption exercise
Common Stock
+497,396$0.00$010,591,406Jul 1, 2025
Jun 2, 2025MOption exercise
Common Stock
+476,070$0.00$011,067,476Jul 1, 2025
Jun 27, 2025POpen-market purchase
Common Stock
+166$1.06$17611,067,642Jul 1, 2025
Jun 30, 2025POpen-market purchase
Common Stock
+1,000$0.98$98011,068,642Jul 1, 2025
Jun 30, 2025POpen-market purchase
Common Stock
+2,000$1.01$2,02011,070,642Jul 1, 2025
Jun 30, 2025POpen-market purchase
Common Stock
+1,450$1.02$1,47911,072,092Jul 1, 2025
Jun 30, 2025POpen-market purchase
Common Stock
+700$1.03$72111,072,792Jul 1, 2025
Jun 30, 2025POpen-market purchase
Common Stock
+1,500$1.04$1,56011,074,292Jul 1, 2025
Jun 30, 2025POpen-market purchase
Common Stock
+1,000$1.05$1,05011,075,292Jul 1, 2025

Related signals

Other insiders at JUPITER NEUROSCIENCES, INC. and this insider’s other filings.

ScoreCompanyInsiderValueHoldingsFiled
33Weak
JUNSbuy 2
JUPITER NEUROSCIENCES, INC.
Christer Rosen
CEO and Chairman
$3,667
3,600 shares
+0%
23Weak
JUNSbuy 2
JUPITER NEUROSCIENCES, INC.
Alison D. Silva
Pres + Chief Business Officer
$772
750 shares
+1%
23Weak
JUNSbuy 2
JUPITER NEUROSCIENCES, INC.
Alison D. Silva
Pres + Chief Business Officer
$1,855
1,800 shares
+2%

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

Christer Rosen bought $7,986 of JUNS | InsiderTell